Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma.

Lianjun ZhaoYu RenGuiying ZhangKelin ZhengJiayu WangHuizi ShaMengke ZhaoRong HuangDonglin KangXinyu SuYirong WuWangling ZhangRuihe LaiLin LiRui MeiYitao WangYou TianFufeng WangBaorui Liu Zhengyun Zou

Published in: Journal for immunotherapy of cancer (2024)

Chinese Clinical Trial Registry, ChiCTR1900023277.

Keyphrases

clinical trial
open label
randomized controlled trial
phase ii
ulcerative colitis
double blind